Douglas E. Linn
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 4
- Cancer-related gene regulation 2
-
- Prostate Cancer Treatment and Research 10
- Co-authors
- Yun Qiu (9 shared papers)Feng Sun (4 shared papers)Richeng Jiang (3 shared papers)Jonathan Melamed (4 shared papers)Hegang Chen (5 shared papers)Xi Yang (4 shared papers)Zhiyong Guo (4 shared papers)Hege Chen (3 shared papers)
- Journals
- Cancer Research (5 papers)Journal of Biological Chemistry (2 papers)PLoS ONE (2 papers)Cell Reports (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Douglas E. Linn
17 papers receiving 1.5k citations
Douglas E. Linn's Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 899
- Cancer Research 322
- Endocrinology, Diabetes and Metabolism 204
- Oncology 298
- Molecular Biology 752
Countries citing papers authored by Douglas E. Linn
This map shows the geographic impact of Douglas E. Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Linn more than expected).
Fields of papers citing papers by Douglas E. Linn
This network shows the impact of papers produced by Douglas E. Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Linn. The network helps show where Douglas E. Linn may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas E. Linn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth Hit paper breakdown → | 2009 | 699 |
| 2 | 2009 | 183 | |
| 3 | 2013 | 139 | |
| 4 | 2010 | 83 | |
| 5 | 2010 | 76 | |
| 6 | 2018 | 67 | |
| 7 | 2013 | 59 | |
| 8 | 2010 | 54 | |
| 9 | 2012 | 52 | |
| 10 | 2008 | 51 | |
| 11 | 2016 | 28 | |
| 12 | 2020 | 8 | |
| 13 | 2007 | 7 | |
| 14 | 2017 | 5 | |
| 15 | 2015 | 5 | |
| 16 | 2013 | 4 | |
| 17 | 2018 | 1 |
About Douglas E. Linn
Douglas E. Linn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Hematology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Mechanisms and Therapy (5 papers), Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (4 papers), Estrogen and related hormone effects (2 papers), Hormonal and reproductive studies (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (899 citations), Cancer Research (322 citations), Endocrinology, Diabetes and Metabolism (204 citations), Oncology (298 citations) and Molecular Biology (752 citations). Douglas E. Linn has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Yun Qiu, Feng Sun, Richeng Jiang, Jonathan Melamed, Hegang Chen, Xi Yang, Zhiyong Guo, Hege Chen, Xiangtian Kong and Angela Brodie. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, PLoS ONE, Cell Reports and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.